Trials / Unknown
UnknownNCT03603548
Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Medical University of Warsaw · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Adult patients after liver transplantation initially treated with traditional Tacrolimus variant- Prograf, switched on day 10 after orthotropic liver transplantation (OLTx) on prolonged released Tacrolimus variant in 1:1 ratio ( Advagraf vs. Envarsus)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Envarsus | Patients after liver transplantation initially treated with traditional Tacrolimus variant- Prograf, switched on day 10 after OLTx on prolonged released Tacrolimus variant in 1:1 ratio ( Advagraf vs. Envarsus) |
| DRUG | Advagraf | Patients after liver transplantation initially treated with traditional Tacrolimus variant- Prograf, switched on day 10 after OLTx on prolonged released Tacrolimus variant in 1:1 ratio ( Advagraf vs. Envarsus) |
Timeline
- Start date
- 2018-07-09
- Primary completion
- 2023-07-09
- Completion
- 2023-07-09
- First posted
- 2018-07-27
- Last updated
- 2018-07-27
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT03603548. Inclusion in this directory is not an endorsement.